Table 1.
Group | bw (g) | TC (mg/dL) | TG (mg/dL) | NEFA (mEq/L) | Adipo (ng/mL) | Insulin (ng/mL) |
---|---|---|---|---|---|---|
N | 26.843 ± 1.18a | 58.789 ± 7.96a | 76.633 ± 17.91a | 0.646 ± 0.00 | 1.972 ± 195 | 0.4167 ± 0.24a |
NCE | 24.100 ± 0.66a | 82.456 ± 8.79a | 91.022 ± 8.86a | 0.751 ± 0.02 | 1.574 ± 1.56 | 0.1695 ± 0.03a |
2DM | 45.729 ± 1.99b | 155.678 ± 36.95b | 229.800 ± 31.62b | 1.430 ± 0.16 | 9.637 ± 0.81 | 8.4123 ± 2.79b |
2DMCE | 44.300 ± 1.82b | 120.677 ± 18.77ab | 157.633 ± 21.30c | 1.295 ± 0.09 | 8.237 ± 0.67 | 2.2831 ± 1.00a |
Values are expressed as mean ± SD, n = 3/group.
The alphabetical symbols a, b, and c on the right shoulder of the number indicate intergroup comparisons. Different superscript letters indicate statistically significant differences among groups (P < 0.05).
N: nondiabetic normal control group. Mice were orally administered 1-mL pure water for 8 weeks. NCE: CE-treated nondiabetic normal control group. CE (100 mg/kg bw/day) was orally administered for 8 weeks.
2DM type 2 diabetes model mice group. Mice were orally administered 1-mL pure water for 8 weeks, 2DMCE CE-treated type 2 diabetes model mice group. CE (100 mg/kg bw/day) was orally administered for 8 weeks, bw body weight, TC plasma total cholesterol content, TG plasma triglyceride content, NEFA plasma nonesterified fatty acid content, Adipo plasma adiponectin content, Insulin plasma insulin content.